The omnibus Healthcare Bill, over-the-counter (OTC) medication distribution, and the draft regulation on food and drugs supervision were among the key issues discussed during AmCham’s Pharmaceuticals and Medical Devices Committee meeting held on April 17 at Abbott Indonesia's office.
The session kicked off with a brief overview of main industry issues with the omnibus Healthcare Bill, including halal requirements for health-related products, government use of patents and compulsory licensing, and prioritization of domestic health products. The committee agreed to coordinate with other relevant stakeholders and further monitor the development of the Bill, especially in regard to its implementing regulations.
The bill is also expected to allow foreign-trained doctors to finally practice medicine in Indonesia, an issue AmCham has long supported.
The session continued with the discussion of other pressing issues, such as OTC medication distribution and the draft regulation on food and drugs supervision. Member companies also shared insights and experiences on other policy issues and made suggestions for future advocacy plans. For further details on the committee, please contact [email protected].
For opportunity for additional visibility please contact: [email protected]
